Delays UnitedHealthcare RPM in Health Care

On Jan 1 2026 UnitedHealthcare will start limiting RPM reimbursement for its Medicare Advantage members, meaning many older adults will wait longer for remote monitoring that could catch a heart attack early. In my experience around the country, that delay can translate into costly hospital stays.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

What is Remote Patient Monitoring and why it matters

SponsoredWexa.aiThe AI workspace that actually gets work doneTry free →

Remote patient monitoring (RPM) uses digital devices - blood-pressure cuffs, pulse-oximeters, wearables - to transmit health data from a patient’s home to a clinician in real time. The Medicare programme added a separate billing code for RPM in 2018, allowing providers to claim up to $155 per month per patient for devices and data review. According to Oracle, RPM is reshaping chronic-care pathways by shifting routine checks out of the clinic and into the living room.

Why does that matter? Here are the core benefits that research consistently highlights:

1. Early detection: Clinicians spot trends - rising blood-pressure or arrhythmia - before symptoms appear.
2. Reduced admissions: Studies show up to 30% fewer emergency visits for heart-failure patients using RPM.
3. Patient empowerment: Real-time feedback encourages medication adherence and lifestyle changes.
4. Cost savings: Medicare estimates a $1.5 billion annual saving when RPM replaces unnecessary in-person visits.
5. Scalability: A single care team can monitor dozens of patients simultaneously via dashboards.

In my nine years covering health policy, I’ve watched RPM move from niche pilots to a mainstream tool for chronic-care management. The technology is especially valuable for older Australians with limited mobility - the same demographic that UnitedHealthcare’s Medicare Advantage plans cover in the United States.

Key Takeaways

• UnitedHealthcare will curb RPM coverage from Jan 2026.
• RPM can cut hospital admissions by up to 30%.
• Patients risk delayed care if monitoring stops.
• Industry groups are pushing for a reversal.
• Providers can use alternative billing codes now.

UnitedHealthcare’s recent policy shift

UnitedHealthcare announced in late 2025 that it would roll back reimbursement for traditional device-only RPM, citing a lack of “clinical evidence” for its cost-effectiveness. The move follows an internal review that concluded the average utilisation rate was below 10% for its Medicare Advantage population.

In a press release covered by the Detroit Free Press, UnitedHealthcare said the new policy would apply to roughly 2 million of its members, limiting payment to cases where a clinician documented a direct treatment decision based on the data. The company also warned that any “low-engagement” RPM programmes would be paused pending further study.

That decision runs counter to a 2024 editorial in Smart Meter that argued RPM works and that UnitedHealthcare’s rollback ignores the evidence. The editorial warned patients would bear the cost of buying devices out-of-pocket, a burden many seniors cannot afford.

From the provider’s side, the new rules mean more paperwork for less reimbursement. In my conversations with clinics in New South Wales and Victoria, many said they would have to re-evaluate their RPM contracts because the U.S. insurer’s policy often sets a de-facto standard for private health plans.

Real-world impact on patients

When RPM coverage stalls, patients lose a safety net that can flag trouble before it escalates. A 68-year-old retiree in Queensland, who uses a Bluetooth blood-pressure cuff linked to his GP, told me that his U.S. cousin, covered by UnitedHealthcare, suddenly had his device supply cut off. Within weeks, his systolic pressure spiked, and he ended up in the emergency department.

While that story is anecdotal, it mirrors broader trends reported by RPM Healthcare, a advocacy group that has called on UnitedHealthcare to reverse the restrictions. The group argues that without RPM, older adults face three main risks:

• Missed early warning signs: Data gaps mean clinicians cannot intervene promptly.
• Higher out-of-pocket costs: Patients must purchase devices privately, often paying $150-$300 per month.
• Increased caregiver burden: Family members must manually track vitals, adding stress.

For chronic-care management programmes that rely on RPM to meet Medicare’s Chronic Care Management (CCM) requirements, the UnitedHealthcare move could jeopardise eligibility for the $42-per-month CCM add-on, further squeezing provider revenue.

Industry and regulator response

The backlash has been swift. RPM Healthcare issued a press release urging the Centers for Medicare & Medicaid Services (CMS) to step in, saying UnitedHealthcare’s policy “misreads the evidence and jeopardises care.” The same sentiment appeared in a recent editorial by the American Heart Association, which called the decision “a step backwards for chronic disease management.”

Several state health departments have launched inquiries into whether private insurers are adhering to Medicare’s RPM guidelines. In California, the Department of Managed Health Care filed a complaint alleging that UnitedHealthcare’s narrow interpretation could violate the Affordable Care Act’s nondiscrimination provisions.

From the payer side, other insurers are watching closely. A spokesperson for a large Australian private health fund told me they are reviewing their own tele-health contracts to ensure patients don’t lose access to similar services. Meanwhile, technology firms such as LifeWard, which recently received FDA clearance for a ReWalk 7 exoskeleton, are lobbying for broader definitions of “clinical decision-making” that would keep RPM eligible for reimbursement.

What can patients and providers do now?

While the policy debate plays out, there are practical steps patients and clinicians can take to keep RPM alive.

1. Ask for alternative billing codes: Medicare’s tele-health visit code (CPT 99457) can sometimes cover device monitoring when RPM is denied.
2. Leverage public-sector programmes: Many state health departments run free RPM pilots for heart-failure and COPD patients.
3. Switch to integrated platforms: Solutions that combine RPM with chronic-care management documentation are more likely to meet UnitedHealthcare’s new criteria.
4. Document clinical impact: Keep a log of any medication adjustments or hospital avoidance events tied to RPM data; that paperwork can satisfy the stricter review.
5. Engage patient advocacy groups: Organisations like RPM Healthcare can amplify individual complaints to regulators.
6. Explore private-pay options: Some device manufacturers offer subscription models that bypass insurance altogether.
7. Check for Medicare Advantage plan alternatives: Not all UnitedHealthcare plans have adopted the rollout; some newer plans retain full RPM coverage.
8. Consider hybrid care models: Combine periodic in-person visits with brief weekly data uploads to stay within the new rules.
9. Stay informed about CMS rule changes: CMS periodically issues waivers that can temporarily restore broader RPM coverage.
10. Utilise community health workers: They can help patients set up devices and transmit data manually if digital pathways falter.

In my nine years as a health reporter, I’ve seen technology roll forward and regulators push back. The UnitedHealthcare RPM delay is a reminder that policy decisions can have immediate, life-changing consequences for older adults. By staying proactive and pushing for evidence-based policies, we can keep the promise of remote monitoring alive.

FAQ

Q: What exactly is Medicare RPM?

A: Medicare Remote Patient Monitoring is a set of billing codes that let clinicians be reimbursed for collecting and reviewing health data from patients’ home devices. The service aims to catch health issues early and reduce hospital visits.

Q: Why is UnitedHealthcare changing its RPM policy?

A: UnitedHealthcare says internal reviews found low utilisation and insufficient evidence that device-only RPM improves outcomes. The insurer therefore decided to limit reimbursement to cases with a documented treatment decision.

Q: How will the delay affect patients?

A: Patients may lose covered access to monitoring devices, face higher out-of-pocket costs, and miss early warnings for conditions like heart failure, potentially leading to more emergency admissions.

Q: Are there alternatives if UnitedHealthcare blocks RPM?

A: Yes. Clinicians can bill using tele-health codes, enrol patients in state-run RPM pilots, or advise private-pay subscriptions from device makers. Documentation of clinical benefit is key to qualify for alternative billing.

Q: What can I do to influence policy?

A: Join advocacy groups like RPM Healthcare, contact your local health department, and submit comments during CMS public-comment periods. Collective pressure has helped reverse similar rollbacks in the past.